- Friday December 21: Sanchita P. Ghosh, PhD, Research Biologist, Radiation Countermeasures Program, AFRRI: Review of gamma-tocotrienol, a radiation prophylaxis agent. Related information:
- Friday, December 14: Michael Abend, Prof. Dr. med. M.Sc./Colonel (MC), Deputy Director, Bundeswehr Institute of Radiobiology, Neuherbergstr 11, 80937 Munich, Germany: NATO biodosimetry study—Comparison of established and emerging biodosimetry assay. Related information:
- Friday, December 7: LT Joshua M. Swift, PhD, Combined Injury Program, AFRRI: Bad to the bone: Radiation and combined injury effects on skeletal tissue. Related information:
- Friday, November 30: Edward J. Calabrese, Professor, University of Massachusetts, School of Public Health and Health Sciences, Amherst, MA: Chemical and radiation hormesis: Toxicological foundations and biomedical applications. Related information:
- Friday, November 9: Mang Xiao, MD, Research Biologist, Radiation Countermeasures Program, AFRRI: Updated studies: Radioprotective effects of delta-tocotrienol and serum microRNA30c levels in gamma-irradiated mice. Related information:
- Friday, November 2: Shilpa Kulkarni, PhD, Staff Investigator, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI): Development of gamma-tocotrienol as a radiation countermeasure. Related information:
- Friday, October 26: Alexandra C. Miller, PhD, Senior Research Scientist, Radiation Countermeasures Program, AFRRI: Radiation leukemia: Genetic and epigenetic mechanisms. Related information:
- Friday, September 14: Regina Marie Day, PhD, Associate Professor, Department of Pharmacology, School of Medicine, USUHS: Captopril mitigates radiation effects in a murine model of dual hematopoietic and pulmonary injuries. Related information:
- Friday, September 7: Brian E. Livingston, Capt, USAF, BSC, Military Medical Operations, AFRRI: Bringing AFRRI to the troops: MMO readiness and outreach.
- Friday, August 24: Mr. Barrett N. Fountos, MS, Program Manager/Health Scientist, Office of Domestic and International Health Studies, U.S. Department of Energy, Germantown, MD: Recent research results from the Russian Health Studies Program. Related information:
- Friday, July 6: Merriline M. Satyamitra, PhD, Research Scientist (HMJF), Radiation Countermeasures Program, AFRRI: The NIAID-AFRRI radiation countermeasure screening program. Related Information:
- Friday, June 22: Caroline H. Johnson, PhD, Postdoctoral Fellow, Laboratory of Metabolism, National Cancer Institute, NIH: Metabolomics for the discovery of urinary biomarkers of ionizing radiation exposure in non-human primates. Related information:
- Friday, June 8: Carl A. Curling, ScD; Research Staff Member; Strategy, Forces and Resources Division; Institute for Defense Analyses, Alexandria, VA: CBRN casualty estimation. Related information:
- Friday, June 1: Maria Moroni, PhD, Research Associate (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Efficacy of G-CSF administration and identification of an accelerated bone marrow syndrome in a minipig model of ARS. Related information:
- Friday, May 18: Xinyue Lu, MD, PhD, Research Scientist (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Radioprotective effect of 17-DMAG in mice. Related Information:
- Friday, May 11:
Zheng Wang, PhD, Research Biologist, Naval Research Laboratory, Washington, DC: Transcriptomic analysis reveals adaptation of the black yeast to the low dose of ionizing radiation. Related information:
- Friday, April 27: Kushal Chakraborty, PhD, Staff Investigator (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Combined effect of GT3 and simvastatin on radiation induced hematopoietic injury. Related information:
- Friday, April 20: Gregory L. King, PhD, Research Physiologist,
Radiation Countermeasures Program, AFRRI: Acute response to space radiation: Prodromal syndrome in ferrets. Related information:
- Friday, April 13: Risaku Fukumoto, PhD, Research Associate, Henry M. Jackson Foundation (Radiation Combined Injury Program, AFRRI): Ciprofloxacin: Not just an antimicrobial. Related information:
- Friday, April 6: Cam T. Ha, PhD, Research Scientist, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI): Genistein inhibits radiation-induced inflammation and protects mouse hematopoietic tissue. Related information:
- Friday, March 30: Thomas B. Elliott, PhD, Research Microbiologist, Combined Injury Program, AFRRI: Procalcitonin as a biomarker to detect radiation-induced sepsis in mice and to monitor therapy. Related information:
- Friday, March 16: Mark H. Whitnall, PhD, Program Advisor, Radiation Countermeasures Program, AFRRI: Gottingen minipig model of acute radiation syndrome (ARS). Related information:
- Friday, March 9: Lynnette Cary, PhD, Staff Scientist (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Endothelial cell regulation of hematopoietic cells after radiation injury. Related information:
- Friday, March 2: Michael R. Landauer, PhD, Research Toxicologist, AFRRI: Isoflavone-induced radiation protection: Current status. Related information:
-
Friday, February 24: William F. Blakely, PhD, Program Advisor, Biological Dosimetry, AFRRI: Update on translational biodosimetry research activities. Related information:
- Friday, February 17: Joel Lowy, PhD, Principal Investigator, AFRRI: Responses of innate immune system cells to combined exposure to radiation and PAMPs.
- Friday, February 10: Natalia I. Ossetrova, PhD, Research Biologist, Biological Dosimetry Program, AFRRI: Further evaluation of combined proteomic and hematological approach for biodosimetry applications. Related information:
- Friday, February 3: MAJ Eric D. Lombardini, VMD, Chief, Division of Comparative Pathology, Veterinary Sciences Department, AFRRI: Tissue collection for histopathology in various laboratory species. Related information:
- Friday, January 20: Nikolai Gorbunov, PhD, Henry M. Jackson Foundation (Combined Injury Program, AFRRI), Bethesda, MD: Response of mouse mesenchymal stromal cells (MSCs) to challenge with Escherichia coli: A proposed defense role of MSCs in the tissue barriers. Related information:
- Friday, January 13: Juliann G. Kiang, PhD, Program Advisor, Combined Injury Program, AFRRI: Ciprofloxacin as a drug to treat radiation combined injury. Related information:
|